1. |
Brown DM, Schmidt-Erfurth U, Do DV, et al. Intravitreal aflibercept for diabetic macular edema: 100-week results from the VISTA and VIVID Studies[J]. Ophthalmology, 2015, 122(10): 2044-2052. DOI: 10.1016/j.ophtha.2015.06.017.
|
2. |
Heier JS, Korobelnik JF, Brown DM, et al. Intravitreal aflibercept for diabetic macular edema: 148-week results from the VISTA and VIVID Studies[J]. Ophthalmology, 2016, 123(11): 2376-2385. DOI: 10.1016/j.ophtha.2016.07.032.
|
3. |
Brown DM, Nguyen QD, Marcus DM, et al. Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase Ⅲ trials: RISE and RIDE[J]. Ophthalmology, 2013, 120(10): 2013-2022. DOI: 10.1016/j.ophtha.2013.02.034.
|
4. |
Rajendram R, Fraser-Bell S, Kaines A, et al. A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3[J]. Arch Ophthalmol, 2012, 130(8): 972-979.
|
5. |
Wang J, Quan Y, Dalal R, et al. Comparison of continuous-wave and micropulse modulation in retinal laser therapy[J]. Invest Ophthalmol Vis Sci, 2017, 58(11): 4722-4732. DOI: 10.1167/iovs.17-21610.
|
6. |
Luttrull JK, Dorin G. Subthreshold diode micropulse laser photocoagulation (SDM) as invisible retinal phototherapy for diabetic macular edema: a review[J]. Curr Diabetes Rev, 2012, 8(4): 274-284. DOI: 10.2174/157339912800840523.
|
7. |
Vujosevic S, Martini F, Longhin E, et al. Subthreshold micropulse yellow laser versus subthreshold micropulse infrared laser in center-involving diabetic macular edema: morphologic and functional safety[J]. Retina, 2015, 35(8): 1594-1603. DOI: 10.1097/IAE.0000000000000521.
|
8. |
Vujosevic S, Martini F, Convento E, et al. Subthreshold laser therapy for diabetic macular edema: metabolic and safety issues[J]. Curr Med Chem, 2013, 20(26): 3267-3271. DOI: 10.2174/09298673113209990030.
|
9. |
Moisseiev E, Abbassi S, Thinda S, et al. Subthreshold micropulse laser reduces anti-VEGF injection burden in patients with diabetic macular edema[J]. Eur J Ophthalmol, 2018, 28(1): 68-73. DOI: 10.5301/ejo.5001000.
|
10. |
孙光丽, 姜静, 王成虎, 等. 高密度微脉冲激光联合玻璃体内注射雷珠单抗治疗糖尿病性黄斑水肿[J]. 眼科新进展, 2017, 37(3): 279-281. DOI: 10.13389/j.cnki.rao.2017.0070.Sun GL, Jiang J, Wang CH, et al. High-density micropulse photocoagulation combined with intravitreal injection of ranibizumab for diabetic macular edema[J]. Rec Adv Ophthalmol, 2017, 37(3): 279-281. DOI: 10.13389/j.cnki.rao.2017.0070.
|
11. |
Wells JA, Glassman AR, Ayala AR, et al. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema: two-year results from a comparative effectiveness randomized clinical trial[J]. Ophthalmology, 2016, 123(6): 1351-1359. DOI: 10.1016/j.ophtha.2016.02.022.
|
12. |
Bressler SB, Glassman AR, Almukhtar T, et al. Five-year outcomes of ranibizumab with prompt or deferred laser versus laser or triamcinolone plus deferred ranibizumab for diabetic macular edema[J]. Am J Ophthalmol, 2016, 164: 57-68. DOI: 10.1016/j.ajo.2015.12.025.
|
13. |
Elman MJ, Ayala A, Bressler NM, et al. Intravitreal Ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: 5-year randomized trial results[J]. Ophthalmology, 2015, 122(2): 375-381. DOI: 10.1016/j.ophtha.2014.08.047.
|
14. |
Mansouri A, Sampat KM, Malik KJ, et al. Efficacy of subthreshold micropulse laser in the treatment of diabetic macular edema is influenced by pre-treatment central foveal thickness[J]. Eye (Lond), 2014, 28(12): 1418-1424. DOI: 10.1038/eye.2014.264.
|
15. |
Li Z, Song Y, Chen X, et al. Biological modulation of mouse RPE cells in response to subthreshold diode micropulse laser treatment[J]. Cell Biochem Biophys, 2015, 73(2): 545-552. DOI: 10.1007/s12013-015-0675-8.
|
16. |
Roider J, Michaud N, Flotte T, et al. Histology of retinal lesions after continuous irradiation and selective micro-coagulation of the retinal pigment epithelium[J]. Ophthalmologe, 1993, 90(3): 274-278.
|